Internal Medicine, Rheumatology · Miami Shores, FL
NPI
1629396486
Since 2010
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
209 NE 95th St Suite 4
Miami Shores, FL, 33138
Phone (786) 206-8610
Groups this clinician bills Medicare through
Medicare paid, 2024
$956K
77,569 services
Medicare patients, 2024
532
Average age 77
Drug cost, 2024
$1.8M
2,103 prescriptions
Company payments, 2025
$3,782
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luis A Arias-Urdaneta was code J3111 (injection, romosozumab-aqqg, 1 mg), 30,240 times for 28 patients. In total Luis A Arias-Urdaneta billed 77,569 services in 35 codes, and Medicare paid $956K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 30,240 | 28 | $8.10 | $245K |
| J0897 Injection, denosumab, 1 mg | Office | 22,740 | 227 | $19.09 | $434K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,608 | 68 | $0.10 | $471 |
| 96401 Chemotherapy Administration | Office | 703 | 251 | $56.24 | $40K |
| 99214 Office E&M - Established | Office | 454 | 250 | $99.35 | $45K |
| 99213 Office E&M - Established | Office | 412 | 227 | $70.19 | $29K |
| 99204 Office E&M - New | Office | 171 | 171 | $122.64 | $21K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 120 | 24 | $4.76 | $571 |
| 20611 Joint Injection | Office | 94 | 44 | $67.04 | $6,302 |
| 20610 Joint Injection | Office | 78 | 40 | $52.15 | $4,067 |
| 96365 Intravenous Infusion, Hydration | Office | 64 | 35 | $50.02 | $3,201 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 35 | 25 | $4.58 | $160 |
| J7327 Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 35 | 21 | $538.55 | $19K |
By year: 2022 $725K for 58,184 services; 2023 $792K for 66,991 services; 2024 $956K for 77,569 services.
Medicare prescription drug claims, 2024
In 2024, the drug Luis A Arias-Urdaneta prescribed most often to Medicare patients was Prednisone, with 288 prescriptions and refills. In total Luis A Arias-Urdaneta wrote 2,103 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 288 | 430 | 95 | $1,087 |
| Methotrexate Methotrexate Sodium | 202 | 470 | 58 | $4,054 |
| Alendronate Sodium Generic | 192 | 468 | 62 | $1,463 |
| Prolia Denosumab | 192 | 1,152 | 115 | $341K |
| Duloxetine Hcl Generic | 140 | 291 | 49 | $2,636 |
| Hydroxychloroquine Sulfate Generic | 138 | 307 | 46 | $3,299 |
| Gabapentin Generic | 96 | 209 | 36 | $2,036 |
| Folic Acid Generic | 84 | 236 | 27 | $678 |
| Allopurinol Generic | 71 | 178 | 18 | $307 |
| Tramadol Hcl Generic | 54 | 54 | 25 | $650 |
| Leflunomide Generic | 49 | 106 | 16 | $1,696 |
| Colchicine Generic | 44 | 68 | 11 | $3,012 |
| Evenity (2 Syringes) Romosozumab-Aqqg | 35 | 35 | Under 11 | $88K |
| Diclofenac Sodium Generic | 33 | 39 | 11 | $1,794 |
| Tymlos Abaloparatide | 33 | 33 | Under 11 | $97K |
Brand drugs: 464 claims; generic drugs: 1,639 claims; opioid claims: 55.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luis A Arias-Urdaneta $3,782 ($3,782 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $883.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 35 | $883 |
| Janssen Biotech, Inc. JNJ | 19 | $527 |
| Mallinckrodt Hospital Products Inc. | 14 | $379 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $325 |
| UCB, Inc. UCB.BR | 13 | $284 |
| Amgen Inc. AMGN | 13 | $271 |
| E.R. Squibb & Sons, L.L.C. BMY | 13 | $262 |
| Radius Health, Inc. | 13 | $259 |
| Pfizer Inc. PFE | 5 | $128 |
| Genzyme Corporation SNY | 3 | $75.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.